期刊文献+

阿托伐他汀对高胆固醇-动脉粥样硬化兔脑组织的抗氧化应激作用研究 被引量:5

Study of Atorvastatin protection of the brain tissues of rabbits with Hypercholesterolemia-AS from oxidative stress
下载PDF
导出
摘要 目的建立兔高胆固醇-动脉粥样硬化模型,观察阿托伐他汀对脑组织的抗氧化应激保护作用。方法24只健康新西兰白兔随机分为3组:(A组)正常对照组、(B组)高脂饮食组和(C组)高脂饮食加阿托伐他汀组。喂饲8周后,测定兔血清总胆固醇(TC)及低密度脂蛋白(LDL)浓度,取脑组织检测血红素氧合酶(HO-1)水平、超氧化物歧化酶(SOD)活力及丙二醛(MDA)含量的变化。结果ABC三组HO-1平均吸光度值分别为0.418200±0.001874,0.682100±0.001853,0.918800±0.001549;SOD值分别为424.03±14.45、271.79±13.46和402.38±7.35;MDA值分别为16.66±2.55、40.87±2.78和21.57±2.19。与对照组相比,高脂饮食组HO-1表达显著上调,SOD活力下降,MDA含量增加(P<0.05);阿托伐他汀组较高脂饮食组HO-1表达进一步上调,SOD活力升高,MDA含量降低(P<0.05)。结论兔动脉粥样硬化过程中,脑组织处于氧化应激状态,阿托伐他汀可对抗氧化应激损伤,从而减缓动脉粥样硬化的形成。 Objective To establish model of rabbit with hypercholesterolemia-AS and investigate the influence of Atorvastatin to the expression of heine oxygenase-1 (HO-1),SOD and MDA in the brain tissues. Methods Twenty-four healthy New-Zealand albino rabbits were divided into three groups randomly: (A group) normal control, (B group) high cholesterol diet, (C group) high cholesterol diet and Atorvastatin. After feeding for eight weeks, we would collect the empty stomach blood samples of these rabbits and determine the density of the total cholesterel(TC)and low density lipoprotein(LDL). To extract their brains and detect the expression of HO-1, the activity of SOD,the amount of MDA. Results Average optical density of HO-1 in A,B and C group respectively: 0.418200 ±0.001874, 0.682100 ±0.001853, 0.918800 ±0.001549. The activity of SOD respectively:424.03 ± 14.45,271.79 ± 13.46,402.38 ±7.35. The amount of MDA respectively: 16.66 ±2.55,40.87 ±2.78,21.57 ±2.19. The HO-1 expression of high cholesterol diet group is increased significantly compared to normal control group. While the activity of SOD was lowered and the amount of MDA was increased (P〈0.05). The HO-1 expression of Atorvastatin Group is increased significantly compared to High Cholesterol Diet Group .While the activity of SOD was increased and the amount of MDA was lowered (P〈0.05). Conclusion The brain tissue is at the state of oxidative stress when AS taking place. Atorvastatin can alleviate this oxidative stress damage on brain tissue and step down the proceeding of AS.
出处 《中国心血管病研究》 CAS 2008年第7期545-547,共3页 Chinese Journal of Cardiovascular Research
关键词 高胆固醇 氧化应激 阿托伐他汀 Hypercholesterelemia Oxidative stress Atorvastatin
  • 相关文献

参考文献7

  • 1[1]Yokoyama M.Oxidant stress and atheroselerosis.Curr Opin Pharmacol,2004,4:110-115.
  • 2刘虹彬,温进坤,韩梅.氧化应激与动脉粥样硬化[J].中国动脉硬化杂志,2001,9(4):360-362. 被引量:22
  • 3[3]Madamanchi NR,Hakim ZS,Runge MS.Oxidative stress in atherogenesis and arterial thrombosis:the disconnected between cellular studies and clinical outcomes.J Thromb Haemost,2005,3:254-267.
  • 4[4]Francois M,Kojda G.Effect of hypercholeaterolemia and oxidative stress on the nitric oxide-cGMP pathway.Neurochem Int,2004,45:955-961.
  • 5[5]Shah AM,Channon KM.Free radicals and redox signaling in cardiovascular disease.Heart,5004,90:486-487.
  • 6[6]Maier CM,Chan PH.Role of superoxide dismutases in oxidative damage and neurodegenerative disorders.Neuroseientist,2002,8:323-334.
  • 7李迎,卢峰,张庆华.阿托伐他汀治疗冠状动脉病变的临床观察[J].中国心血管病研究,2004,2(6):434-435. 被引量:8

二级参考文献14

  • 1[2]Lea AP, Mc Tavish D. Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidemias [ J ]. Drugs, 1997, 53 (6): 828- 847
  • 2[4]Coli S,Eligini S, Lalli M, et al. Vastatins inhibit tissue factor in cultured human macrophages: a novel mechanism of protection against atherothrombosis [ J ]. Arterioscler Thromb Vasc Biol, 1997,17(3): 265 - 272
  • 3Lee S,J Immunol,1997年,158卷,3401页
  • 4Zeiher A M,Circulation Research,1995年,76卷,980页
  • 5MaziereC,FEBS Lett,1995年,363卷,277页
  • 6Yan S D,JBiolChem,1994年,269卷,9889页
  • 7Jiang C,Nature,1998年,391卷,82页
  • 8Chiu J J,Arterioscler Thromb Vasc Biol,1997年,17卷,3570页
  • 9Yang C M,Br J Pharmacol,2001年,132卷,7期,1531页
  • 10Law R E,Circulation,2000年,101卷,11期,1311页

共引文献28

同被引文献37

  • 1罗朝淑,万英,李著华.氧化低密度脂蛋白在动脉粥样硬化发病机理中的作用[J].四川生理科学杂志,2005,27(1):23-25. 被引量:18
  • 2何喜民,向定成,何建新,洪长江,邱健,马骏,张金霞.不同类型心绞痛患者低密度脂蛋白及氧化型低密度脂蛋白的比较研究[J].中华心血管病杂志,2007,35(5):451-454. 被引量:8
  • 3蒋博,刘宏斌.血红素加氧酶与动脉粥样硬化[J].中国组织工程研究与临床康复,2007,11(21):4221-4224. 被引量:3
  • 4Cai L, Kang YJ. Widetive stress and diabetic cardiomyopathy: a brief review [ J ]. Cardiovasc Ttoxico1,2001,1 : 181-193.
  • 5Cai L, Kang YJ. Call death and diabetic cardiomy [ J ]. Cardiovase Toaicol, 2003,3 : 219 -228.
  • 6Asbun J, Villarreal FJ. The pathogenesis of myocardial firosis in the setting of diabetic cardimyopathy [ J ]. Am coil cardio, 2006,47 : 693- 700.
  • 7Calderiai M. Diastolic dysfanction and diabetic cardiomy o pcothy: evalucdion by Doppler echo cardiogrnphy [ J]. J AM coil cardiol, 2006,48 : 1548-1551.
  • 8Tavazzi L, Tognoni G, Franzosi MG, et al. GISSI. Investigators. Rationle and design of the GISSI heart failure trial:a large trial to assess the effects of n-3 pllyun scdurated futty acids and rosuvastatin in sympomatic congestive heart failure [ J ]. Eur J Heart Fail ,2004,6:635-641.
  • 9Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improues cardiac function and symptoms in patients with idiopcothic dilated cardiomyipathy [ J ]. Circulation ,2003,108 ( 7 ) :839-853.
  • 10Gtil-ortegs I, Carlo S, Kaski J. Diabetic myocardiopcothy [ J ]. Mod clin ,2006,127:584-594.

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部